内部人交易记录
其他基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Jorgensen Nathan D.. Director active across 2 companies, notably Vor Biopharma Inc.. Aggregated, 15 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €31k. Activity tracked since 1 September 2022. The latest transaction was filed on 3 October 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Jorgensen Nathan D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
7,666 股@ US$4.78Common StockSEC:0001104659-25-097522:0
51,500 股0Common StockSEC:0001104659-25-016510:0
80,000 股0Common StockSEC:0001104659-24-105438:0
834 股@ US$1.751.9% 占其流量Common StockSEC:0001415889-24-012459:0
917 股@ US$1.772.1% 占其流量Common StockSEC:0001415889-24-012157:0
6,310 股@ US$2.2718.1% 占其流量Common StockSEC:0001415889-24-006594:0
985 股@ US$2.322.9% 占其流量Common StockSEC:0001415889-24-003036:0
50,000 股0Common StockSEC:0001415889-24-002096:0
834 股@ US$1.821.9% 占其流量Common StockSEC:0001209191-23-054696:0
6,310 股@ US$2.6721.2% 占其流量Common StockSEC:0001209191-23-048387:0
834 股@ US$2.672.8% 占其流量Common StockSEC:0001209191-23-045192:0
834 股@ US$4.144.3% 占其流量Common StockSEC:0001209191-23-028462:0
6,310 股@ US$5.5144.9% 占其流量Common StockSEC:0001209191-23-014918:0
45,500 股0Common StockSEC:0001209191-23-007782:0
86,000 股0Common StockSEC:0001209191-22-048724:0
About Jorgensen Nathan D.
Nathan D. Jorgensen is a declarant linked to Vor Biopharma Inc. and Voyager Therapeutics, Inc., where the stated role is Chief Financial Officer. The record shows 14 filings, all within the tracked sample from 2022-09-06 to 2025-02-24, with the dominant transaction nature listed as Tax withholding and buy and sell amounts of 0.